Recovery research fieldbook Evidence, not treatment advice
Recovery archive

Published recovery field note

MK-677 and Tesa/IPA Protocol Interaction: Monitor | Peptide Database

Can you take MK-677 with Tesa/IPA Protocol? Monitor interaction (90% confidence). See pharmacological analysis, organ load, safety flags, and dosing guidance.

Context first

Study findings do not automatically establish clinical benefit, safety, dosing, or suitability for an individual.

Compound Profiles

MK-677

Ghrelin Receptor Agonist | Oral Growth Hormone Secretagogue

Selectively binds GHS-R1a receptors in hypothalamus and pituitary, triggering pulsatile growth hormone release while maintaining natural circadian patterns..

Tesa/IPA Protocol

Tesamorelin + Ipamorelin GH Secretagogue Blend

The blend leverages two distinct GH-releasing pathways: Tesamorelin is a synthetic GHRH analog that directly stimulates growth hormone-releasing hormone receptors on pituitary somatotrophs, triggering GH synthesis and secretion in a pulsatile, physiological manner. Ipamorelin is a selective ghrelin receptor (GHS-R1a) agonist that amplifies GH pulses without significantly affecting cortisol or prolactin.

Combined Organ Load

Shared Safety Flags

Frequently Asked Questions

Can I take MK-677 with Tesa/IPA Protocol?

Yes, but with caution. Both affect GH release; combination may be excessive and affect glucose. Regular monitoring is advised.

Is MK-677 and Tesa/IPA Protocol safe together?

Based on documented research, this combination is considered monitor. However, shared safety flags include: carcinogenic risk, insulin disrupting, teratogenic. Monitor accordingly.

What are the interactions between MK-677 and Tesa/IPA Protocol?

Both affect GH release; combination may be excessive and affect glucose. This assessment has 90% confidence and is based on documented research data.

This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.

Connected topics

Follow this recovery question